The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients. [electronic resource]
Producer: 20141203Description: 828732 p. digitalISSN:- 2314-7156
- Adult
- Antibodies -- blood
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Chronic Disease
- Disease Progression
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Glomerular Filtration Rate
- Graft Rejection -- blood
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Immunologic Factors -- therapeutic use
- Kidney Transplantation
- Male
- Middle Aged
- Renal Insufficiency, Chronic -- immunology
- Rituximab
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.